Results 191 to 200 of about 2,422,567 (286)

Next-generation flow cytometry analysis of clonal bone marrow plasma cells identifies an indolent subset of MGUS. [PDF]

Blood Adv
Óskarsson JÞ, Thorsteinsdottir S, Rögnvaldsson S, Ólafsson A, Viðarsdóttir G, Guðmundsdóttir ER, Eythorsson E, Jónsson Á, Viðarsson B, Önundarson PT, Agnarsson BA, Sigurðardóttir M, Þorsteinsdóttir I, Ólafsson Í, Harding SJ, Durie BG, Love TJ, Kristinsson SY.   +17 more
europepmc   +1 more source

Immune‐Driven Expression in Inclusion Body Myositis With T‐Cell Large Granular Lymphocytic Leukemia

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives T‐cell large granular lymphocytic leukemia (T‐LGLL), reported in up to 58% of inclusion body myositis (IBM) patients, is a rare leukemia of cytotoxic or less commonly helper T cells. The range of myopathies in T‐LGLL and the impact of coexisting T‐LGLL in IBM are not well understood. Our objectives are to investigate the spectrum of
Pannathat Soontrapa, Iago Pinal‐Fernandez, Pritikanta Paul, Michael P. Skolka, Margherita Milone, Min Shi, Mithun V. Shah, Maria Casal‐Dominguez, Katherine Pak, Andrew L. Mammen, Teerin Liewluck   +10 more
wiley   +1 more source

B cell maturation antigen (BCMA) is dispensable for the survival of long-lived plasma cells. [PDF]

Nat Commun
Menzel SR, Roth E, Wittner J, Brey S, Weckwerth L, Thomas J, Winkler TH, Schuh W, Jäck HM, Pracht K, Schulz SR.   +10 more
europepmc   +1 more source

Characterization of Clinical Phenotype to Glial Fibrillary Acidic Protein Concentrations in Alexander Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To determine the concentration of glial fibrillary acidic protein (GFAP) in cerebrospinal fluid (CSF) and plasma in Alexander disease (AxD) and whether GFAP levels are predictive of disease phenotypes. Methods CSF and plasma were collected (longitudinally when available) from AxD participants and non‐AxD controls.
Amy T. Waldman, Asako Takanohashi, Joshua Y. Joung, Geraldine W. Liu, Kaley Arnold, Amy Pizzino, Walter Faig, Sarah Woidill, Sona Narula, Adeline L. Vanderver   +9 more
wiley   +1 more source

Effects of cladribine on intrathecal and peripheral B and plasma cells. [PDF]

Clin Exp Immunol
Allen-Philbey K, Stephenson S, Doody G, MacDougall A, Aboulwafaali M, Ammoscato F, Andrews M, Gnanapavan S, Giovannoni G, Grigoriadou S, Hickey A, Holden DW, Lock H, Papachatzaki M, Redha I, Baker D, Tooze R, Schmierer K.   +17 more
europepmc   +2 more sources

Daratumumab and isatuximab differentially affect CD38 detection on plasma cells in myeloma: Anti-CD38 nanobody (clone JK36) and CD319 combination improve flow cytometric identification of plasma cells after targeted therapies. [PDF]

Br J Haematol
Shameli A, Catey T, Woodings V, Koepke O, Fromm JR, Cherian S.   +5 more
europepmc   +1 more source

Plasma cell leukemia.

Einstein (Sao Paulo, Brazil), 2013
de Souza, Clarissa Lima e Moura, Perini, Guilherme Fleury, Hamerschlak, Nelson, Silveira, Paulo Augusto Achucarro   +3 more
openaire   +2 more sources

Unraveling the Molecular Mechanisms of Glioma Recurrence: A Study Integrating Single‐Cell and Spatial Transcriptomics

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Glioma recurrence severely impacts patient prognosis, with current treatments showing limited efficacy. Traditional methods struggle to analyze recurrence mechanisms due to challenges in assessing tumor heterogeneity, spatial dynamics, and gene networks.
Lei Qiu, Yinjiao Fei, Jiaxuan Ding, Kexin Shi, Jinyan Luo, Yuchen Zhu, Xingjian Sun, Gefei Jiang, Yuandong Cao, Weilin Xu, Shu Zhou   +10 more
wiley   +1 more source

Recombinant antibodies from clonally expanded cancer-associated plasma cells. [PDF]

Cancer Immunol Immunother
Kim W, Oh JH, Park CW, Kim H, Kang YG, Oh DE, Lee HJ, Kim JH, Sung CO.   +8 more
europepmc   +1 more source

Plasma-cell Mastitis [PDF]

BMJ, 1957
openaire   +2 more sources